# Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella

> **NCT02196285** · PHASE1 · COMPLETED · sponsor: **The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)** · enrollment: 30 (actual)

## Conditions studied

- Rubella
- Measles

## Interventions

- **BIOLOGICAL:** Double viral (MR) vaccine

## Key facts

- **NCT ID:** NCT02196285
- **Lead sponsor:** The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2015-12
- **Final completion:** 2016-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02196285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02196285, "Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02196285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*